AGMB
AgomAb Therapeutics NV
8.70$
+1.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | – | |
| 0.30 | 0.31 | 0.28 | 0.30 | |
| 0.04 | 0.06 | 0.07 | 0.04 | |
| 0.33 | 0.36 | 0.34 | 0.33 | |
| -0.33 | -0.36 | -0.34 | -0.33 | |
| 0.00 | 0.00 | 0.00 | – | |
| -0.32 | -0.43 | -0.36 | -0.32 | |
| 0.00 | – | – | 0.00 | |
| -0.32 | -0.43 | -0.36 | -0.32 | |
| -0.33 | -0.42 | -0.36 | -0.33 |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.